Preferences help
enabled [disable] Abstract
Number of results
2016 | 63 | 1 | 17-29
Article title

Vitamin D in the skin physiology and pathology

Title variants
Languages of publication
Vitamin D plays important, pleiotropic role in the maintenance of global homeostasis. Its influence goes far beyond the regulation of calcium and phosphorus balance, as diverse activities of vitamin D and its natural metabolites assure proper functioning of major human organs, including skin. Recently, we reviewed the current understanding of vitamin D impact on human health from historical perspective (Wierzbicka et al. (2014) The renaissance of vitamin D. Acta Biochim Pol 61: 679-686). This article focuses on its functions in the skin. The skin and its appendages, creates a platform connecting and protecting internal organs against, usually harmful, external environment. It uppermost layer - epidermis in order to maintain a protective barrier undergoes a constant exchange of cornified keratinocytes layer. Its disturbance leads to development of serious skin disorders including psoriasis, vitiligo, atopic dermatitis and skin cancer. All of those dermatopathologies have a huge impact on modern societies, affecting not only the physical, but also mental state of patients as well as their social status. Furthermore, multiple human systemic diseases (autoimmune, blood and digestive diseases) have skin manifestation, thus "condition of the skin" often reflects the condition and pathological changes within the internal organs. In humans, the skin is the natural source of vitamin D, which is produced locally from 7-dehydrocholesterol in photoreaction induced by ultraviolet B (UVB) radiation from the sun. It is also well established, that the process of proliferation and differentiation of keratinocytes is tightly regulated by calcium and the active form of vitamin D (1,25(OH)2D3). Thus, the skin physiology is inseparably connected with vitamin D production and activity. Unfortunately, UVB, which is required for vitamin D production, is also known as the main cause of a skin cancer, including melanoma. Here, we are going to review benefits of vitamin D and its analogues in the maintenance of epidermal barrier and its potential use in the treatment of common skin diseases.
Physical description
  • Department of Histology, Medical University of Gdańsk, Gdańsk, Poland
  • Department of Histology, Medical University of Gdańsk, Gdańsk, Poland
  • Department of Histology, Medical University of Gdańsk, Gdańsk, Poland
  • Abu Tahir M, Pramod K, Ansari SH, Ali J (2010) Current remedies for vitiligo. Autoimmun Rev 9: 516-520.
  • Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4: 404-412.
  • Aksu Cerman A, Sarikaya Solak S, Kivanc Altunay I (2014) Vitamin D deficiency in alopecia areata. Br J Dermatol 170: 1299-304.
  • Ameen M, Exarchou V, Chu AC (2001) Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 145: 476-479.
  • Aris M, Barrio MM. (2015) Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment. Front Immunol 6: 46.
  • Amestejani M, Salehi BS, Vasigh M, Sobhkhiz A, Karami M, Alinia H, Kamrava SK, Shamspour N, Ghalehbaghi B, Behzadi AH (2012) Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol 11: 327-330.
  • Armstrong BK, Kricker A (1993) How much melanoma is caused by sun exposure? Melanoma Res 3: 395-401.
  • Bataille V, de Vries E (2008) Melanoma - Part 1: epidemiology, risk factors, and prevention. BMJ 337: a2249.
  • Bataille V (2013) Sun exposure, sunbeds and sunscreens and melanoma. What are the controversies? Curr Oncol Rep 15: 526-32.
  • Beattie PE, Lewis-Jones MS (2006) A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 155: 145-151.
  • Ben-Shoshan M (2012) Vitamin D deficiency/insufficiency and challenges in developing global vitamin D fortification and supplementation policy in adults. Int J Vitam Nutr Res 82: 237-259.
  • Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C, Barnhill R (2005) Sun exposure and mortality from melanoma. J Natl Cancer Inst 97: 195-199.
  • Bijlsma MF, Spek CA, Zivkovic D, van de Water S, Rezaee F, Peppelenbosch MP (2006) Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol 4: e232.
  • Bikle DD, Pillai S (1993) Vitamin D, calcium, and epidermal differentiation. Endocr Rev 14: 3-19.
  • Bikle DD, Tu CL, Xie Z, Oda Y (2003) Vitamin D regulated keratinocyte differentiation: role of coactivators. J Cell Biochem 88: 290-295.
  • Bikle DD (2004) Vitamin D regulated keratinocyte differentiation. J Cell Biochem 92: 436-444.
  • Bikle DD, Oda Y, Xie Z (2004) Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation. J Steroid Biochem Mol Biol 89-90: 355-360.
  • Bikle DD (2011) Vitamin D metabolism and function in the skin. Mol Cell Endocrinol 347: 80-89.
  • Bikle DD (2012) Vitamin D and the skin: Physiology and pathophysiology. Rev Endocr Metab Disord 13: 3-19.
  • Boelsma E, Pavel S, Ponec M (1995) Effects of calcitriol on fibroblasts derived from skin of scleroderma patients. Dermatology 191: 226-233.
  • Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242: 233-246.
  • Bradford PT (2009) Skin cancer in skin of color. Dermatol Nurs 21: 170-177, 206.
  • Brown AJ, Slatopolsky E (2008) Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol Aspects Med 29: 433-452.
  • Brozyna AA, Zbytek B, Granese J, Carlson AJ, Ross J, Slominski AT (2007) Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Rev Dermatol 2: 451-469.
  • Brozyna AA, Jozwicki W, Janjetovic Z, Slominski AT (2011) Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Hum Pathol 42: 618-631.
  • Brozyna AA, Jozwicki W, Janjetovic Z, Slominski AT (2013) Expression of the vitamin D-activating enzyme 1 alpha-hydroxylase (CYP27B1) decreases during melanoma progression. Human Pathology 44: 374-387.
  • Burfield L, Burden AD (2013) Psoriasis. J R Coll Physicians Edinb 43: 334-338.
  • Burns EM, Elmets CA, Yusuf N (2015) Vitamin D and skin cancer. Photochem Photobiol 91: 201-209.
  • Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, Panageas KS, Busam KJ, Chmielowski B, Lutzky J, Pavlick AC, Fusco A, Cane L, Takebe N, Vemula S, Bouvier N, Bastian BC, Schwartz GK. (2011) KIT as a therapeutic target in metastatic melanoma. Jama 305: 2327-2334.
  • Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW (2004) Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 101: 7711-7715.
  • Chiang KC, Yeh CN, Hsu JT, Chen LW, Kuo SF, Sun CC, Huang CC, Pang JH, Flanagan JN, Takano M, Kittaka A, Juang HH, Yang SW, Chen TC (2013) MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. J Steroid Biochem Mol Biol 138: 427-434.
  • Chignell CF, Kukielczak BM, Sik RH, Bilski PJ, He YY (2006) Ultraviolet A sensitivity in Smith-Lemli-Opitz syndrome: Possible involvement of cholesta-5,7,9(11)-trien-3 beta-ol. Free Radic Biol Med 41: 339-346.
  • Cho SH, Strickland I, Boguniewicz M, Leung DY (2001) Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 108: 269-274.
  • Colston K, Colston MJ, Feldman D (1981) 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108: 1083-1086.
  • Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A (2006) Cutaneous Malignant Melanoma. Mayo Clinic Proceedings 81: 500-507.
  • Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS (1998) Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 39: 211-215.
  • Cust AE, Armstrong BK, Goumas C, Jenkins MA, Schmid H, Hopper JL, Kefford RF, Giles GG, Aitken JF, Mann GJ (2011) Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 128: 2425-2435.
  • Dale BA, Resing KA, Lonsdale-Eccles JD (1985) Filaggrin: a keratin filament associated protein. Ann N Y Acad Sci 455: 330-342.
  • Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7: 684-700.
  • De Haes P, Garmyn M, Verstuyf A, De Clercq P, Vandewalle M, Degreef H, Vantieghem K, Bouillon R, Segaert S (2005) 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J Photochem Photobiol B 78: 141-148.
  • DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80: 1689S-1696S.
  • Dummer R, Hauschild A, Jost L (2008) Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19: ii86-ii88.
  • Eckert RL, Rorke EA (1989) Molecular biology of keratinocyte differentiation. Environ Health Perspect 80: 109-116.
  • Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV, Mehta K (2014) Transglutaminase regulation of cell function. Physiol Rev 94: 383-417.
  • Egan KM (2009) Vitamin D and melanoma. Ann Epidemiol 19: 455-461.
  • Eichner R, Sun TT, Aebi U (1986) The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments. J Cell Biol 102: 1767-1777.
  • Elias PM, Menon GK, Grayson S, Brown BE (1988) Membrane structural alterations in murine stratum corneum: relationship to the localization of polar lipids and phospholipases. J Invest Dermatol 91: 3-10.
  • Ellison TI, Smith MK, Gilliam AC, MacDonald PN (2008) Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J Invest Dermatol 128: 2508-2517.
  • Elst EF, Van Suijlekom-Smit LW, Oranje AP (1999) Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children. Pediatr Dermatol 16: 53-58.
  • Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29: 21-30.
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359-E386.
  • Field S, Davies J, Bishop DT, Newton-Bishop JA (2013) Vitamin D and melanoma. Dermatoendocrinol 5: 121-129.
  • Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185.
  • Fuller LC, Allen MH, Montesu M, Barker JN, Macdonald DM (1996) Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours. Br J Dermatol 134: 28-32.
  • Gapska P, Scott RJ, Serrano-Fernandez P, Mirecka A, Rassoud I, Gorski B, Cybulski C, Huzarski T, Byrski T, Nagay L, Maleszka R, Sulikowski M, Lubinski J, Debniak T (2009) Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Cancer Epidemiol 33: 103-107.
  • Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Spatz A, Grob JJ, Malvehy J, Newton-Bishop J, Stratigos A, Pehamberger H, Eggermont A (2010) Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer 46(2): 270-283.
  • Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN (2011) 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152: 2976-2986.
  • Gniadecki R, Gajkowska B, Hansen M (1997) 1,25-dihydroxyvitamin D3 stimulates the assembly of adherens junctions in keratinocytes: involvement of protein kinase C. Endocrinology 138: 2241-2248.
  • Gordon-Thomson C, Gupta R, Tongkao-on W, Ryan A, Halliday GM, Mason RS (2012) 1α,25 dihydroxyvitamin D3 enhances cellular defences against UV-induced oxidative and other forms of DNA damage in skin. Photochem Photobiol Sci 11: 1837-1847.
  • Gschwandtner M, Zhong S, Tschachler A, Mlitz V, Karner S, Elbe-Burger A, Mildner M (2014) Fetal human keratinocytes produce large amounts of antimicrobial peptides: involvement of histone-methylation processes. J Invest Dermatol 134: 2192-2201.
  • Guo J, Ma Z, Ma Q, Wu Z, Fan P, Zhou X, Chen L, Zhou S, Goltzman D, Miao D, Wu E (2013) 1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Curr Med Chem 20: 4131-4141.
  • Gupta R, Dixon KM, Deo SS, Holliday CJ, Slater M, Halliday GM, Reeve VE, Mason RS (2007) Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol 127: 707-715.
  • Halsall JA, Osborne JE, Epstein MP, Pringle JH, Hutchinson PE (2009) The unfavorable effect of the A allele of the vitamin D receptor promoter polymorphism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma. Dermatoendocrinol 1: 54-57.
  • Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, Kanada K, Yamasaki K, Alexandrescu D, Gallo RL (2008) Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 122: 829-831.
  • Haussler MR, Jurutka PW, Mizwicki M, Norman AW (2011) Vitamin D receptor (VDR)-mediated actions of 1α,25(OH) vitamin D: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 25: 543-559.
  • Hawker NP, Pennypacker SD, Chang SM, Bikle DD (2007) Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3. J Invest Dermatol 127: 874-880.
  • Heath KM, Elovic EP (2006) Vitamin D deficiency: implications in the rehabilitation setting. Am J Phys Med Rehabil 85: 916-923.
  • Heine G, Hoefer N, Franke A, Nothling U, Schumann RR, Hamann L, Worm M (2013) Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults. Br J Dermatol 168: 855-858.
  • Hennings H, Holbrook KA (1983) Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp Cell Res 143: 127-142.
  • Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS (1999) 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res 59: 2644-2649.
  • Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371.
  • Holick MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest 116: 2062-2072.
  • Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
  • Holick MF, Chen TC, Lu Z, Sauter E (2007) Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 22: V28-V33.
  • Holick MF (2011) Vitamin D: a d-lightful solution for health. J Investig Med 59: 872-880.
  • Hossani-Madani A, Halder R (2011) Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes. G Ital Dermatol Venereol 146: 373-395.
  • Hossein-nezhad A, Holick MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88: 720-755.
  • Hsu S, Papp KA, Lebwohl MG, Bagel J, Blauvelt A, Duffin KC, Crowley J, Eichenfield LF, Feldman SR, Fiorentino DF, Gelfand JM, Gottlieb AB, Jacobsen C, Kalb RE, Kavanaugh A, Korman NJ, Krueger GG, Michelon MA, Morison W, Ritchlin CT, Stein Gold L, Stone SP, Strober BE, Van Voorhees AS, Weiss SC, Wanat K (2012) Consensus guidelines for the management of plaque psoriasis. Arch Dermatol 148: 95-102.
  • Hu L, Bikle DD, Oda Y (2014) Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation. J Steroid Biochem Mol Biol 144: 237-241.
  • Hulshof MM, Pavel S, Breedveld FC, Dijkmans BA, Vermeer BJ (1994) Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 130: 1290-1293.
  • Hulshof MM, Bouwes Bavinck JN, Bergman W, Masclee AA, Heickendorff L, Breedveld FC, Dijkmans BA (2000) Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol 43: 1017-1023.
  • Hutchinson PE, Osborne JE, Lear JT, Smith AG, Bowers PW, Morris PN, Jones PW, York C, Strange RC, Fryer AA (2000) Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 6: 498-504.
  • Janjetovic Z, Zmijewski MA, Tuckey RC, DeLeon DA, Nguyen MN, Pfeffer LM, Slominski AT (2009) 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One 4: e5988.
  • Janjetovic Z, Tuckey RC, Nguyen MN, Thorpe EM Jr, Slominski AT (2010) 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J Cell Physiol 223: 36-48.
  • Kamradt J, Rafi L, Mitschele T, Meineke V, Gartner BC, Wolfgang T, Holick MF, Reichrath J (2003) Analysis of the vitamin D system in cutaneous malignancies. Recent Results Cancer Res 164: 259-269.
  • Kang S, Yi S, Griffiths CE, Fancher L, Hamilton TA, Choi JH (1998) Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions. Br J Dermatol 138: 77-83.
  • Karthaus N, van Spriel AB, Looman MW, Chen S, Spilgies LM, Lieben L, Carmeliet G, Ansems M, Adema GJ (2014) Vitamin d controls murine and human plasmacytoid dendritic cell function. J Invest Dermatol 134: 1255-1264.
  • Kim TK, Wang J, Janjetovic Z, Chen J, Tuckey RC, Nguyen MN, Tang EK, Miller D, Li W, Slominski AT (2012) Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength. Mol Cell Endocrinol 361: 143-152.
  • Klymkowsky MW, Parr B (1995) The body language of cells: the intimate connection between cell adhesion and behavior. Cell 83: 5-8.
  • Kmieć P, Żmijewski M, Waszak P, Sworczak K, Lizakowska-Kmieć M (2014) Vitamin D deficiency during winter months among an adult, predominantly urban, population in Northern Poland. Endokrynol Pol 65: 105-113.
  • Kmieć P, Żmijewski M, Lizakowska-Kmieć M, Sworczak K (2015) Widespread vitamin D deficiency among adults from northern Poland (54°N) after months of low and high natural UVB radiation. Endokrynol Pol 66: 30-38.
  • Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, Reichrath J (2009) The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 29: 3511-3536.
  • Leiter U, Eigentler T, Garbe C (2014) Epidemiology of skin cancer. Adv Exp Med Biol 810: 120-140.
  • Li C, Liu Z, Zhang Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei Q (2007) Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J Invest Dermatol 127: 276-280.
  • Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA (2009) Increasing burden of melanoma in the United States. J Invest Dermatol 129: 1666-1674.
  • Lundqvist J, Yde CW, Lykkesfeldt AE (2014) 1α,25-dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells. Steroids 85: 30-35.
  • Malodobra-Mazur M, Paduch A, Lebioda A, Konopacka M, Rogolinski J, Szymczyk C, Wierzgon J, Maciejewski A, Chmielik E, Jonkisz A, Poltorak S, Dobosz T (2012) VDR gene single nucleotide polymorphisms and their association with risk of oral cavity carcinoma. Acta Biochim Pol 59: 627-630.
  • Manolagas SC, Provvedini DM, Tsoukas CD (1985) Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 43: 113-122.
  • Matheson EM, Mainous AG 3rd, Hueston WJ, Diaz VA, Everett CJ (2010) Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage. Scand J Infect Dis 42: 455-460.
  • Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T (1996) E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 56: 4063-4070.
  • Menon GK, Grayson S, Elias PM (1985) Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 84: 508-512.
  • Mesquita Kde C, Igreja AC, Costa IM (2013) Atopic dermatitis and vitamin D: facts and controversies. An Bras Dermatol 88: 945-953.
  • Michel G, Gailis A, Jarzebska-Deussen B, Muschen A, Mirmohammadsadegh A, Ruzicka T (1997) 1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells. Inflamm Res 46: 32-34.
  • Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122: 398-417.
  • Mitschele T, Diesel B, Friedrich M, Meineke V, Maas RM, Gartner BC, Kamradt J, Meese E, Tilgen W, Reichrath J (2004) Analysis of the vitamin D system in basal cell carcinomas (BCCs). Lab Invest 84: 693-702.
  • Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24.
  • Montes LF, Pfister R, Elizalde F, Wilborn W (2003) Association of vitiligo with Sjogren's syndrome. Acta Derm Venereol 83: 293.
  • Morimoto S, Kumahara Y (1985) A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Med J Osaka Univ 35: 51-54.
  • Moukayed M, Grant WB (2013) Molecular link between vitamin D and cancer prevention. Nutrients 5: 3993-4021.
  • Mutgi K, Koo J (2013) Update on the role of systemic vitamin D in atopic dermatitis. Pediatr Dermatol 30: 303-307.
  • Nagpal S, Lu J, Boehm MF (2001) Vitamin D analogs: mechanism of action and therapeutic applications. Curr Med Chem 8: 1661-1679.
  • Narayanan DL, Saladi RN, Fox JL (2010) Ultraviolet radiation and skin cancer. Int J Dermatol 49: 978-986.
  • Nedoszytko B, Sokolowska-Wojdylo M, Ruckemann-Dziurdzinska K, Roszkiewicz J, Nowicki RJ (2014) Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis. Postepy Dermatol Alergol 31: 84-91.
  • Nelson A (2001) Localized sclerodermas. In Textbook of pediatric rheumatology. Cassidy JT, Petty RE, eds, pp 535-544. W. B. Saunders, Philadelphia.
  • Nemere I, Garbi N, Hammerling G, Hintze KJ (2012) Role of the 1,25D3-MARRS receptor in the 1,25(OH)2D3-stimulated uptake of calcium and phosphate in intestinal cells. Steroids 77: 897-902.
  • Newton-Bishop JA, Chang YM, Elliott F, Chan M, Leake S, Karpavicius B, Haynes S, Fitzgibbon E, Kukalizch K, Randerson-Moor J, Elder DE, Bishop DT, Barrett JH (2011) Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur J Cancer 47: 732-741.
  • Niepomniszcze H, Amad RH (2001) Skin disorders and thyroid diseases. J Endocrinol Invest 24: 628-638.
  • O'Leary RE, Diehl J, Levins PC (2014) Update on tanning: More risks, fewer benefits. J Am Acad Dermatol 70: 562-568.
  • Oda Y, Sihlbom C, Chalkley RJ, Huang L, Rachez C, Chang CP, Burlingame AL, Freedman LP, Bikle DD (2004) Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in VDR transactivation during keratinocyte differentiation. J Steroid Biochem Mol Biol 89-90: 273-276.
  • Oda Y, Ishikawa MH, Hawker NP, Yun QC, Bikle DD (2007) Differential role of two VDR coactivators, DRIP205 and SRC-3, in keratinocyte proliferation and differentiation. J Steroid Biochem Mol Biol 103: 776-780.
  • Oda Y, Uchida Y, Moradian S, Crumrine D, Elias PM, Bikle DD (2009) Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J Invest Dermatol 129: 1367-1378.
  • Oikawa A, Nakayasu M (1974) Stimulation of melanogenesis in cultured melanoma cells by calciferols. FEBS Lett 42: 32-35.
  • Okuno H, Kishimoto KN, Hatori M, Itoi E (2012) 1α,25-dihydroxyvitamin D₃ enhances fast-myosin heavy chain expression in differentiated C2C12 myoblasts. Cell Biol Int 36: 441-447.
  • Osborne JE, Hutchinson PE (2002) Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol 147: 197-213.
  • Penna G, Adorini L (2000) 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405-2411.
  • Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL (2011) Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol 164: 1078-1082.
  • Peterson AL, Murchison C, Zabetian C, Leverenz JB, Watson GS, Montine T, Carney N, Bowman GL, Edwards K, Quinn JF (2013) Memory, mood, and vitamin D in persons with Parkinson's disease. J Parkinsons Dis 3: 547-555.
  • Pillai S, Bikle DD, Elias PM (1988) Vitamin D and epidermal differentiation: evidence for a role of endogenously produced vitamin D metabolites in keratinocyte differentiation. Skin Pharmacol 1: 149-160.
  • Pillai S, Bikle DD (1991) Role of intracellular-free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D3. J Cell Physiol 146: 94-100.
  • Pillai S, Bikle DD, Su MJ, Ratnam A, Abe J (1995) 1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels. J Clin Invest 96: 602-609.
  • Pinczewski J, Slominski A (2010) The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms. Exp Dermatol 19: 860-864.
  • Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181-1183.
  • Pludowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokol D, Czech-Kowalska J, (2013) Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 64: 319-327.
  • Pludowski P, Grant WB, Bhattoa HP, Bayer M, Povoroznyuk V, Rudenka E, Ramanau H, Varbiro S, Rudenka A, Karczmarewicz E, Lorenc R, Czech-Kowalska J, Konstantynowicz J (2014) Vitamin d status in central europe. Int J Endocrinol 2014: 589587.
  • Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, Kukalizch K, Affleck P, Leake S, Haynes S, Karpavicius B, Marsden J, Gerry E, Bale L, Bertram C, Field H, Barth JH, Silva Idos S, Swerdlow A, Kanetsky PA, Barrett JH, Bishop DT, Bishop JA (2009) Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 45: 3271-3281.
  • Ratnam AV, Bikle DD, Cho JK (1999) 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes. J Cell Physiol 178: 188-196.
  • Reichrath J, Nurnberg B (2009) Cutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation. Dermatoendocrinol 1: 253-261.
  • Reichrath J, Rass K (2014) Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update. Adv Exp Med Biol 810: 208-233.
  • Saleh HM, Abdel Fattah NS, Hamza HT (2013) Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases. Photodermatol Photoimmunol Photomed 29: 34-40.
  • Searing DA, Leung DY (2010) Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin North Am 30: 397-409.
  • Sehgal VN, Rege VL, Mascarenhas F, Kharangate VN (1976) Clinical pattern of vitiligo amongst Indians. J Dermatol 3: 49-53.
  • Seline PC, Norris DA, Horikawa T, Fujita M, Middleton MH, Morelli JG (1996) Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. J Invest Dermatol 106: 1320-1324.
  • Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. (2008) Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. In Br J Dermatol 159: 245-247.
  • Silverberg JI, Silverberg AI, Malka E, Silverberg NB (2010) A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol 62: 937-941.
  • Slominski A, Li W, Bhattacharya SK, Smith RA, Johnson PL, Chen J, Nelson K, Tuckey RC, Miller D, Jiao Y, Gu W, Postlethwaite AE (2011) Vitamin D analogs 17,20S(OH)2pD and 17,20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. J Invest Dermatol 131: 1167-1169.
  • Slominski AT, Janjetovic Z, Kim TK, Wright AC, Grese LN, Riney SJ, Nguyen MN, Tuckey RC (2012) Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes. Anticancer Res 32: 3733-3742.
  • Slominski A, Janjetovic Z, Tuckey RC, Nguyen MN, Bhattacharya KG, Wang J, Li W, Jiao Y, Gu W, Brown M, Postlethwaite AE (2013a) 20S-Hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo. J Clin Endocrinol Metab 98: E298-E303.
  • Slominski A, Kim TK, Li W, Yi AK, Postlethwaite A, Tuckey RC (2013b) The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J Steroid Biochem Mol Biol 144: 28-39.
  • Slominski A, Kim TK, Zmijewski MA, Janjetovic Z, Li W, Chen J, Kusniatsova EI, Semak I, Postlethwaite A, Miller DD, Zjawiony JK, Tuckey RC (2013c) Novel vitamin D photoproducts and their precursors in the skin. Dermatoendocrinol 5: 7-19.
  • Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, Li W, Janjetovic Z, Postlethwaite A, Zouboulis CC, Tuckey RC (2013d) Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol 137: 107-123.
  • Slominski AT, Zmijewski MA, Semak I, Zbytek B, Pisarchik A, Li W, Zjawiony J, Tuckey RC (2014a) Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem 14: 77-96.
  • Slominski AT, Kim TK, Li W, Yi AK, Postlethwaite A, Tuckey RC (2014b) The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J Steroid Biochem Mol Biol 144: 28-39.
  • Slominski AT, Brozyna A, Jozwicki W, Tuckey RC (2015a) Vitamin D as an adjuvant in melanoma therapy. Melanoma Manag 2: 1-4.
  • Slominski AT, Janjetovic Z, Kim TK, Wasilewski P, Rosas S, Hanna S, Sayre RM, Dowdy JC, Li W, Tuckey RC (2015b) Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation. J Steroid Biochem Mol Biol 148: 52-63.
  • Stawczyk-Macieja M, Szczerkowska-Dobosz A, Rebala K, Purzycka-Bohdan D (2015) Genetic background of skin barrier dysfunction in the pathogenesis of psoriasis vulgaris. Postepy Dermatol Alergol 32: 123-126.
  • Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park HW (2008) Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol 380: 95-106.
  • Su MJ, Bikle DD, Mancianti ML, Pillai S (1994) 1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium. J Biol Chem 269: 14723-14729.
  • Szyszka P, Zmijewski MA, Slominski AT (2012) New vitamin D analogs as potential therapeutics in melanoma. Expert Rev Anticancer Ther 12: 585-599.
  • Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, Inoue M, Monden T, Ito F, Monden M (1996) Beta-catenin expression in human cancers. Am J Pathol 148: 39-46.
  • Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S (1997) 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277: 1827-1830.
  • Tang JY, So PL, Epstein EH Jr. (2007) Novel Hedgehog pathway targets against basal cell carcinoma. Toxicol Appl Pharmacol 224: 257-264.
  • Tang EK, Chen J, Janjetovic Z, Tieu EW, Slominski AT, Li W, Tuckey RC (2013) Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1. Drug Metab Dispos 41: 1112-1124.
  • Thacher SM, Rice RH (1985) Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell 40: 685-695.
  • Thill M, Woeste A, Reichert K, Fischer D, Rody A, Friedrich M, Köster F (2015) Vitamin D inhibits ovarian cancer cell line proliferation in combination with celecoxib and suppresses cyclooxygenase-2 expression. Anticancer Res 35: 1197-1203.
  • Wacker M, Holick MF (2013) Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol 5: 51-108.
  • Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909-2912.
  • Warhol MJ, Roth J, Lucocq JM, Pinkus GS, Rice RH (1985) Immuno-ultrastructural localization of involucrin in squamous epithelium and cultured keratinocytes. J Histochem Cytochem 33: 141-149.
  • Wasiewicz T, Szyszka P, Cichorek M, Janjetovic Z, Tuckey RC, Slominski AT, Zmijewski MA (2015) Antitumor effects of vitamin D analogs on hamster and mouse melanoma cell lines in relation to melanin pigmentation. Int J Mol Sci 16: 6645-6667.
  • Webb AR, DeCosta BR, Holick MF (1989) Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab 68: 882-887.
  • Wierzbicka J, Piotrowska A, Żmijewski MA (2014) The renaissance of vitamin D. Acta Biochim Pol 61: 679-686.
  • Wierzbicka JM, Binek A, Ahrends T, Nowacka JD, Szydlowska A, Turczyk L, Wasiewicz T, Wierzbicki PM, Sadej R, Tuckey RC, Slominski AT, Chybicki J, Adrych K, Kmiec Z, Zmijewski MA (2015) Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture. Int J Oncol 47: 1084-1096.
  • Wood AW, Chang RL, Huang MT, Uskokovic M, Conney AH (1983) 1 alpha, 25-Dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. Biochem Biophys Res Commun 116: 605-611.
  • Yin L, Ordóñez-Mena JM, Chen T, Schöttker B, Arndt V, Brenner H (2013) Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Prev Med 57: 753-764.
  • Ylikomi T, Laaksi I, Lou YR, Martikainen P, Miettinen S, Pennanen P, Purmonen S, Syvälä H, Vienonen A, Tuohimaa P (2002) Antiproliferative action of vitamin D. Vitam Horm 64: 357-406.
  • Yuan L, Jiang R, Yang Y, Ding S, Deng H (2012) 1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway. Oncol Rep 28: 2131-2137.
  • Zabul P, Wozniak M, Slominski AT, Preis K, Gorska M, Korozan M, Wieruszewski J, Zmijewski MA, Zabul E, Tuckey R, Kuban-Jankowska A, Mickiewicz W, Knap N. (2015) A proposed molecular mechanism of high-dose vitamin D3 supplementation in prevention and treatment of preeclampsia. Int J Mol Sci 16: 13043-13064.
  • Zbytek B, Janjetovic Z, Tuckey RC, Zmijewski MA, Sweatman TW, Jones E, Nguyen MN, Slominski AT (2008) 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol 128: 2271-2280.
  • Zinser GM, Suckow M, Welsh J (2005) Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol 97: 153-164.
  • Zmijewski MA, Li W, Zjawiony JK, Sweatman TW, Chen J, Miller DD, Slominski AT (2009) Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3beta, 17alpha, 20-triol and their bioactivity in melanoma cells. Steroids 74: 218-228.
  • Zmijewski MA, Li W, Chen J, Kim TK, Zjawiony JK, Sweatman TW, Miller DD, Slominski AT (2011) Synthesis and photochemical transformation of 3β,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity. Steroids 76: 193-203.
  • Zouboulis CC, Makrantonaki E (2011) Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol 29: 3-14.
  • Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, Espada G, Corona F, Mukame M, Vesely R, Musiej-Nowakowska E, Chaitow J, Ros J, Apaz MT, Gerloni V, Mazur-Zielinska H, Nielsen S, Ullman S, Horneff G, Wouters C, Martini G, Cimaz R, Laxer R, Athreya BH (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52: 2873-2881.
  • Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. (2006) Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) 45: 614-620.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.